Title |
T cell senescence and CAR-T cell exhaustion in hematological malignancies
|
---|---|
Published in |
Journal of Hematology & Oncology, July 2018
|
DOI | 10.1186/s13045-018-0629-x |
Pubmed ID | |
Authors |
Dimitri Kasakovski, Ling Xu, Yangqiu Li |
Abstract |
T cell senescence has been recognized to play an immunosuppressive role in the aging population and cancer patients. Strategies dedicated to preventing or reversing replicative and premature T cell senescence are required to increase the lifespan of human beings and to reduce the morbidity from cancer. In addition, overcoming the T cell terminal differentiation or senescence from lymphoma and leukemia patients is a promising approach to enhance the effectiveness of adoptive cellular immunotherapy (ACT). Chimeric antigen receptor T (CAR-T) cell and T cell receptor-engineered T (TCR-T) cell therapy highly rely on functionally active T cells. However, the mechanisms which drive T cell senescence remain unclear and controversial. In this review, we describe recent progress for restoration of T cell homeostasis from age-related senescence as well as recovery of T cell activation in hematological malignancies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 20% |
Comoros | 1 | 10% |
Russia | 1 | 10% |
China | 1 | 10% |
Spain | 1 | 10% |
Unknown | 4 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 80% |
Science communicators (journalists, bloggers, editors) | 1 | 10% |
Scientists | 1 | 10% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 289 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 47 | 16% |
Student > Ph. D. Student | 42 | 15% |
Student > Master | 34 | 12% |
Student > Bachelor | 30 | 10% |
Student > Doctoral Student | 17 | 6% |
Other | 39 | 13% |
Unknown | 80 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 63 | 22% |
Immunology and Microbiology | 40 | 14% |
Medicine and Dentistry | 31 | 11% |
Agricultural and Biological Sciences | 24 | 8% |
Engineering | 11 | 4% |
Other | 31 | 11% |
Unknown | 89 | 31% |